Agios Pharmaceuticals Inc (AGIO) 104.05 $AGIO
Hot Drugmakers Build More Labs, Grab Space In Boston
at Investor's Business Daily - 1 hr 7 mins ago
The greater Boston area has seen an influx of some fast-growing biotechs like Biogen Idec (BIIB) that have been taking lab space, a trend that's driven down vacancy rates in a big way. That's under way while the the biotech sector is surging -- IBD's...
BIIB: 341.18 (-6.16), ARE: 88.12 (+1.73), GILD: 101.82 (+0.94), BAX: 73.57 (-0.16), PFE: 31.67 (-0.08), AMGN: 166.55 (-1.52), AGIO: 104.05 (+2.03)
Jim Cramer Picks 19 Companies That Should Get Acquired in 2015
at The Street - Thu Dec 04, 1:00PM CST
Owning the stock of a likely takeover candidate can result in tidy profits. TheStreet's Jim Cramer names 19 companies he thinks could be bought or broken up in 2015.
KMI: 41.46 (-0.37), MNST: 106.61 (-0.35), MDLZ: 38.41 (-0.26), AWAY: 31.85 (-0.03), NKE: 99.05 (+0.55), GRUB: 34.05 (-2.03), GMCR: 134.38 (-1.53), SKX: 60.80 (+0.22), KRFT: 59.70 (-0.49), K: 66.09 (-0.29), JACK: 75.87 (+0.42), YHOO: 50.41 (+0.13), CMG: 663.97 (+12.70), HAWK: 36.14 (+0.09), TWTR: 38.79 (-0.27), Z: 115.16 (-0.02), CST: 43.04 (-0.17), KO: 43.50 (-0.30), BWP: 16.77 (+0.01), NCR: 28.86 (-0.38), VFC: 74.21 (-0.36), TRIP: 77.22 (+1.49), FRGI: 56.97 (-0.71), LULU: 45.92 (+0.21), DRI: 57.85 (-0.26), CELG: 113.63 (-0.60), ADS: 278.66 (-2.79), WWAV: 34.52 (-1.23), HAIN: 114.07 (+1.59), MPC: 96.67 (+0.65), CPB: 43.65 (-0.14), AGIO: 104.05 (+2.03), PAY: 35.96 (+0.15), YELP: 55.14 (+0.37), GIS: 53.00 (-0.04)
Jim Cramer on the Stock Market: You Have to Love Biotech
at The Street - Wed Dec 03, 11:29AM CST
In this era of turmoil, investors can take comfort in this sector.
BIIB: 341.18 (-6.16), AVNR: 16.96 (+0.04), AMGN: 166.55 (-1.52), AGIO: 104.05 (+2.03), REGN: 423.21 (-1.20), NVS: 95.77 (+0.11), CELG: 113.63 (-0.60)
Jim Cramer's Five Best Stock Picks for the Biotech Sector
at The Street - Tue Dec 02, 10:11AM CST
TheStreet's Jim Cramer has selected 12 sectors where he thinks investors should put their money. Biotech stocks have had a "monstrous" year. Here are Cramer's best picks.
BIIB: 341.18 (-6.16), BMRN: 89.96 (-1.14), RNA: 18.96 (-0.01), ISIS: 52.68 (-0.93), AGIO: 104.05 (+2.03), GSK: 45.89 (-0.82), SNY: 46.75 (-1.36), REGN: 423.21 (-1.20), CELG: 113.63 (-0.60)
Agios's Cancer Treatment Has Potential But Does The Stock Have Further Upside?
Kanak Kanti De - at Seeking Alpha - Mon Dec 01, 10:46AM CST
AGIO: 104.05 (+2.03)
Jim Cramer on the Stock Market: Here Are 12 Sectors to Bet On
at The Street - Mon Dec 01, 10:36AM CST
A look at the sectors and top stocks in each
MNST: 106.61 (-0.35), AAP: 153.25 (+1.21), GPC: 103.65 (+0.20), DAL: 46.42 (+1.67), BBY: 36.08 (+0.04), LM: 54.61 (-0.92), INTC: 37.46 (+0.03), VTR: 72.56 (+0.22), HSP: 59.26 (-0.48), UPS: 110.43 (-0.47), COST: 143.02 (+0.33), AAL: 49.65 (+1.41), DG: 67.79 (+1.10), LOW: 64.55 (+0.25), HSIC: 136.76 (-0.12), MA: 88.77 (+0.45), SYK: 94.38 (-0.13), WFM: 48.91 (+0.72), MU: 36.07 (-0.03), BCR: 172.47 (+0.07), PFE: 31.67 (-0.08), EW: 130.00 (-1.46), HIG: 41.31 (-0.22), AZO: 588.07 (-2.48), GILD: 101.82 (+0.94), CVS: 89.84 (+0.70), SHW: 247.71 (+1.26), GD: 144.88 (-0.25), VRX: 144.33 (-0.94), ACT: 267.50 (+1.66), BDX: 140.68 (+0.31), CLX: 99.61 (+0.43), BLK: 360.71 (+3.82), ALTR: 37.50 (-0.13), KMB: 114.60 (-0.10), WSM: 72.52 (-0.45), HUM: 141.12 (-0.59), TSCO: 78.18 (-0.46), YHOO: 50.41 (+0.13), V: 261.14 (-0.46), CMG: 663.97 (+12.70), AAPL: 115.49 (-0.44), PPG: 223.71 (+0.45), TRV: 105.10 (-0.09), ZMH: 113.96 (+0.31), HD: 98.95 (+0.36), ABC: 91.95 (-0.04), PH: 129.77 (-1.72), LRCX: 84.20 (unch), DNB: 123.84 (-1.63), PHM: 21.72 (+0.25), PG: 90.58 (+0.58), ROST: 91.05 (+0.20), BABA: 109.17 (-1.47), MDLZ: 38.41 (-0.26), HON: 99.26 (-0.71), NKE: 99.05 (+0.55), CAH: 82.23 (+0.28), KSU: 118.45 (-1.79), WMT: 84.76 (-0.18), EAT: 56.88 (+0.35), AET: 89.19 (-0.49), AMAT: 24.40 (-0.18), TGT: 73.28 (-0.05), REGN: 423.21 (-1.20), FDX: 180.18 (+0.14), NSC: 107.30 (-4.59), MCK: 211.82 (+0.32), IP: 54.78 (+0.47), VFC: 74.21 (-0.36), CSX: 36.54 (-0.72), BA: 131.32 (-0.65), ALL: 68.39 (+0.32), WLP: 128.71 (+0.94), CELG: 113.63 (-0.60), CBRL: 128.78 (+0.07), MRK: 60.92 (+0.34), XRAY: 55.61 (-0.04), DHI: 24.57 (-0.53), BIIB: 341.18 (-6.16), LMT: 189.73 (+0.05), BMRN: 89.96 (-1.14), SNA: 136.55 (-0.96), RTN: 110.00 (+2.36), UNH: 99.67 (-1.13), CB: 103.61 (+0.18), JBLU: 15.09 (+0.27), LUV: 41.39 (+0.34), PEP: 97.75 (-0.57), DPS: 72.12 (-0.28), SWK: 94.84 (-0.52), WHR: 188.26 (-1.15), UNP: 119.76 (-1.19), GPRO: 71.98 (-1.67), KR: 60.76 (+2.10), HCN: 75.24 (+0.36), ORLY: 188.93 (+0.26), AMGN: 166.55 (-1.52), HPQ: 39.07 (+0.02), DRI: 57.85 (-0.26), CI: 103.19 (-0.84), LEN: 45.77 (-0.52), LB: 82.67 (+0.49), ISIS: 52.68 (-0.93), AGIO: 104.05 (+2.03), KLAC: 70.33 (-0.69)
Biotech Weekly: Biotech From The Charts And What I'm Watching Into Year End
Daniel Ward - at Seeking Alpha - Mon Dec 01, 10:35AM CST
XBI: 178.11 (-1.37), IBB: 306.20 (-2.05), AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Halliburton and Macy's big market movers
AP - Fri Nov 28, 1:09PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FDX: 180.18 (+0.14), DAL: 46.42 (+1.67), NCLH: 44.96 (+0.62), HAL: 40.74 (-0.01), M: 62.50 (-1.16), AGIO: 104.05 (+2.03), SZYM: 2.33 (-0.24)
December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey
at The Street - Wed Nov 26, 5:00AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for health care investors.
BLUE: 42.11 (-0.59), OREX: 5.83 (-0.09), BCRX: 9.92 (-0.66), ALNY: 100.07 (+0.15), ACHN: 13.80 (+0.03), MRK: 60.92 (+0.34), INCY: 74.12 (-0.54), EPZM: 21.51 (-0.01), AGIO: 104.05 (+2.03), ABBV: 69.57 (+1.07), BMY: 58.89 (-0.14), ENTA: 46.25 (+0.03)
Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 20, 3:33PM CST
Shares of Agios Pharmaceuticals (AGIO) soared 14.51% after the company reported positive safety and clinical data on pipeline candidate, AG-120, from an ongoing phase I dose escalation study.
IPXL: 31.58 (-0.59), BIIB: 341.18 (-6.16), AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Best Buy and Activision are big market movers
AP - Thu Nov 20, 3:27PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 14.24 (-0.19), VIPS: 21.75 (+0.16), CLV: 7.55 (-0.60), KIRK: 21.39 (+0.10), BBY: 36.08 (+0.04), CLF: 8.03 (-0.57), WSM: 72.52 (-0.45), CZR: 15.68 (-0.46), DISH: 72.93 (-1.49), ATVI: 21.77 (+0.29), NVAX: 5.35 (-0.07), TGT: 73.28 (-0.05), AGIO: 104.05 (+2.03), OPLK: 24.19 (+0.01), CRM: 58.95 (+0.07)
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 20, 7:51AM CST
Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as its shares rose roughly 15% on the day.
ICUI: 83.89 (-0.69), GWPH: 74.55 (-1.46), AGIO: 104.05 (+2.03), OSUR: 9.62 (-0.16)
Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE
L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
DL: 17.84 (-0.28), SSI: 19.52 (-0.41), EBR: 2.30 (-0.04), AGIO: 104.05 (+2.03)
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO)
at The Street - Wed Nov 19, 1:11PM CST
TheStreet's Jim Cramer explains why investors in Agios Pharmaceuticals (AGIO) are winners and who could buy the $3 billion company.
AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Nasdaq stocks posting largest percentage increases
AP - Wed Nov 19, 12:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
RESN: 8.06 (-0.27), CLUB: 6.01 (-0.04), SPLS: 14.24 (-0.19), FNHC: 24.54 (+0.60), AGIO: 104.05 (+2.03), OPLK: 24.19 (+0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 11:55AM CST
CLUB: 6.01 (-0.04), LEJU: 12.00 (-0.17), ANV: 1.56 (-0.15), SSI: 19.52 (-0.41), ROX: 1.58 (+0.07), CLF: 8.03 (-0.57), BIND: 6.14 (-0.58), NADL: 1.97 (-0.20), CSTM: 17.53 (+0.98), VRML: 1.37 (unch), WTT: 2.62 (+0.09), CANF: 4.04 (-0.23), DL: 17.84 (-0.28), BAMM: 1.87 (+0.03), RELV: 1.25 (+0.03), SNCR: 42.09 (+0.10), ATLC: 2.62 (-0.15), AGIO: 104.05 (+2.03), BBLU: 0.99 (-0.02), OPLK: 24.19 (+0.01)
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'
at The Street - Wed Nov 19, 10:21AM CST
TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.
AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - Wed Nov 19, 8:11AM CST
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 14.24 (-0.19), LEJU: 12.00 (-0.17), TSLA: 228.28 (-1.02), FCAU: 13.22 (-0.34), LITB: 6.12 (-0.37), TTM: 45.39 (-1.65), DL: 17.84 (-0.28), VA: 35.64 (-0.13), TGT: 73.28 (-0.05), GM: 33.09 (-0.55), AGIO: 104.05 (+2.03), LOW: 64.55 (+0.25), HMC: 31.21 (+0.23), EJ: 9.04 (+0.11), PETM: 79.11 (-0.33)
Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:01AM CST
AGIO: 104.05 (+2.03)
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Hot Drugmakers Build More Labs, Grab Space In Boston
at Investor's Business Daily - 1 hr 7 mins ago
The greater Boston area has seen an influx of some fast-growing biotechs like Biogen Idec (BIIB) that have been taking lab space, a trend that's driven down vacancy rates in a big way. That's under way while the the biotech sector is surging -- IBD's...
BIIB: 341.18 (-6.16), ARE: 88.12 (+1.73), GILD: 101.82 (+0.94), BAX: 73.57 (-0.16), PFE: 31.67 (-0.08), AMGN: 166.55 (-1.52), AGIO: 104.05 (+2.03)
Jim Cramer Picks 19 Companies That Should Get Acquired in 2015
at The Street - Thu Dec 04, 1:00PM CST
Owning the stock of a likely takeover candidate can result in tidy profits. TheStreet's Jim Cramer names 19 companies he thinks could be bought or broken up in 2015.
KMI: 41.46 (-0.37), MNST: 106.61 (-0.35), MDLZ: 38.41 (-0.26), AWAY: 31.85 (-0.03), NKE: 99.05 (+0.55), GRUB: 34.05 (-2.03), GMCR: 134.38 (-1.53), SKX: 60.80 (+0.22), KRFT: 59.70 (-0.49), K: 66.09 (-0.29), JACK: 75.87 (+0.42), YHOO: 50.41 (+0.13), CMG: 663.97 (+12.70), HAWK: 36.14 (+0.09), TWTR: 38.79 (-0.27), Z: 115.16 (-0.02), CST: 43.04 (-0.17), KO: 43.50 (-0.30), BWP: 16.77 (+0.01), NCR: 28.86 (-0.38), VFC: 74.21 (-0.36), TRIP: 77.22 (+1.49), FRGI: 56.97 (-0.71), LULU: 45.92 (+0.21), DRI: 57.85 (-0.26), CELG: 113.63 (-0.60), ADS: 278.66 (-2.79), WWAV: 34.52 (-1.23), HAIN: 114.07 (+1.59), MPC: 96.67 (+0.65), CPB: 43.65 (-0.14), AGIO: 104.05 (+2.03), PAY: 35.96 (+0.15), YELP: 55.14 (+0.37), GIS: 53.00 (-0.04)
Jim Cramer on the Stock Market: You Have to Love Biotech
at The Street - Wed Dec 03, 11:29AM CST
In this era of turmoil, investors can take comfort in this sector.
BIIB: 341.18 (-6.16), AVNR: 16.96 (+0.04), AMGN: 166.55 (-1.52), AGIO: 104.05 (+2.03), REGN: 423.21 (-1.20), NVS: 95.77 (+0.11), CELG: 113.63 (-0.60)
Jim Cramer's Five Best Stock Picks for the Biotech Sector
at The Street - Tue Dec 02, 10:11AM CST
TheStreet's Jim Cramer has selected 12 sectors where he thinks investors should put their money. Biotech stocks have had a "monstrous" year. Here are Cramer's best picks.
BIIB: 341.18 (-6.16), BMRN: 89.96 (-1.14), RNA: 18.96 (-0.01), ISIS: 52.68 (-0.93), AGIO: 104.05 (+2.03), GSK: 45.89 (-0.82), SNY: 46.75 (-1.36), REGN: 423.21 (-1.20), CELG: 113.63 (-0.60)
Agios's Cancer Treatment Has Potential But Does The Stock Have Further Upside?
Kanak Kanti De - at Seeking Alpha - Mon Dec 01, 10:46AM CST
AGIO: 104.05 (+2.03)
Jim Cramer on the Stock Market: Here Are 12 Sectors to Bet On
at The Street - Mon Dec 01, 10:36AM CST
A look at the sectors and top stocks in each
MNST: 106.61 (-0.35), AAP: 153.25 (+1.21), GPC: 103.65 (+0.20), DAL: 46.42 (+1.67), BBY: 36.08 (+0.04), LM: 54.61 (-0.92), INTC: 37.46 (+0.03), VTR: 72.56 (+0.22), HSP: 59.26 (-0.48), UPS: 110.43 (-0.47), COST: 143.02 (+0.33), AAL: 49.65 (+1.41), DG: 67.79 (+1.10), LOW: 64.55 (+0.25), HSIC: 136.76 (-0.12), MA: 88.77 (+0.45), SYK: 94.38 (-0.13), WFM: 48.91 (+0.72), MU: 36.07 (-0.03), BCR: 172.47 (+0.07), PFE: 31.67 (-0.08), EW: 130.00 (-1.46), HIG: 41.31 (-0.22), AZO: 588.07 (-2.48), GILD: 101.82 (+0.94), CVS: 89.84 (+0.70), SHW: 247.71 (+1.26), GD: 144.88 (-0.25), VRX: 144.33 (-0.94), ACT: 267.50 (+1.66), BDX: 140.68 (+0.31), CLX: 99.61 (+0.43), BLK: 360.71 (+3.82), ALTR: 37.50 (-0.13), KMB: 114.60 (-0.10), WSM: 72.52 (-0.45), HUM: 141.12 (-0.59), TSCO: 78.18 (-0.46), YHOO: 50.41 (+0.13), V: 261.14 (-0.46), CMG: 663.97 (+12.70), AAPL: 115.49 (-0.44), PPG: 223.71 (+0.45), TRV: 105.10 (-0.09), ZMH: 113.96 (+0.31), HD: 98.95 (+0.36), ABC: 91.95 (-0.04), PH: 129.77 (-1.72), LRCX: 84.20 (unch), DNB: 123.84 (-1.63), PHM: 21.72 (+0.25), PG: 90.58 (+0.58), ROST: 91.05 (+0.20), BABA: 109.17 (-1.47), MDLZ: 38.41 (-0.26), HON: 99.26 (-0.71), NKE: 99.05 (+0.55), CAH: 82.23 (+0.28), KSU: 118.45 (-1.79), WMT: 84.76 (-0.18), EAT: 56.88 (+0.35), AET: 89.19 (-0.49), AMAT: 24.40 (-0.18), TGT: 73.28 (-0.05), REGN: 423.21 (-1.20), FDX: 180.18 (+0.14), NSC: 107.30 (-4.59), MCK: 211.82 (+0.32), IP: 54.78 (+0.47), VFC: 74.21 (-0.36), CSX: 36.54 (-0.72), BA: 131.32 (-0.65), ALL: 68.39 (+0.32), WLP: 128.71 (+0.94), CELG: 113.63 (-0.60), CBRL: 128.78 (+0.07), MRK: 60.92 (+0.34), XRAY: 55.61 (-0.04), DHI: 24.57 (-0.53), BIIB: 341.18 (-6.16), LMT: 189.73 (+0.05), BMRN: 89.96 (-1.14), SNA: 136.55 (-0.96), RTN: 110.00 (+2.36), UNH: 99.67 (-1.13), CB: 103.61 (+0.18), JBLU: 15.09 (+0.27), LUV: 41.39 (+0.34), PEP: 97.75 (-0.57), DPS: 72.12 (-0.28), SWK: 94.84 (-0.52), WHR: 188.26 (-1.15), UNP: 119.76 (-1.19), GPRO: 71.98 (-1.67), KR: 60.76 (+2.10), HCN: 75.24 (+0.36), ORLY: 188.93 (+0.26), AMGN: 166.55 (-1.52), HPQ: 39.07 (+0.02), DRI: 57.85 (-0.26), CI: 103.19 (-0.84), LEN: 45.77 (-0.52), LB: 82.67 (+0.49), ISIS: 52.68 (-0.93), AGIO: 104.05 (+2.03), KLAC: 70.33 (-0.69)
Biotech Weekly: Biotech From The Charts And What I'm Watching Into Year End
Daniel Ward - at Seeking Alpha - Mon Dec 01, 10:35AM CST
XBI: 178.11 (-1.37), IBB: 306.20 (-2.05), AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Halliburton and Macy's big market movers
AP - Fri Nov 28, 1:09PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FDX: 180.18 (+0.14), DAL: 46.42 (+1.67), NCLH: 44.96 (+0.62), HAL: 40.74 (-0.01), M: 62.50 (-1.16), AGIO: 104.05 (+2.03), SZYM: 2.33 (-0.24)
December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey
at The Street - Wed Nov 26, 5:00AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for health care investors.
BLUE: 42.11 (-0.59), OREX: 5.83 (-0.09), BCRX: 9.92 (-0.66), ALNY: 100.07 (+0.15), ACHN: 13.80 (+0.03), MRK: 60.92 (+0.34), INCY: 74.12 (-0.54), EPZM: 21.51 (-0.01), AGIO: 104.05 (+2.03), ABBV: 69.57 (+1.07), BMY: 58.89 (-0.14), ENTA: 46.25 (+0.03)
Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 20, 3:33PM CST
Shares of Agios Pharmaceuticals (AGIO) soared 14.51% after the company reported positive safety and clinical data on pipeline candidate, AG-120, from an ongoing phase I dose escalation study.
IPXL: 31.58 (-0.59), BIIB: 341.18 (-6.16), AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Best Buy and Activision are big market movers
AP - Thu Nov 20, 3:27PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 14.24 (-0.19), VIPS: 21.75 (+0.16), CLV: 7.55 (-0.60), KIRK: 21.39 (+0.10), BBY: 36.08 (+0.04), CLF: 8.03 (-0.57), WSM: 72.52 (-0.45), CZR: 15.68 (-0.46), DISH: 72.93 (-1.49), ATVI: 21.77 (+0.29), NVAX: 5.35 (-0.07), TGT: 73.28 (-0.05), AGIO: 104.05 (+2.03), OPLK: 24.19 (+0.01), CRM: 58.95 (+0.07)
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 20, 7:51AM CST
Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as its shares rose roughly 15% on the day.
ICUI: 83.89 (-0.69), GWPH: 74.55 (-1.46), AGIO: 104.05 (+2.03), OSUR: 9.62 (-0.16)
Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE
L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . DL: 17.84 (-0.28), SSI: 19.52 (-0.41), EBR: 2.30 (-0.04), AGIO: 104.05 (+2.03)
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO)
at The Street - Wed Nov 19, 1:11PM CST
TheStreet's Jim Cramer explains why investors in Agios Pharmaceuticals (AGIO) are winners and who could buy the $3 billion company.
AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Nasdaq stocks posting largest percentage increases
AP - Wed Nov 19, 12:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
RESN: 8.06 (-0.27), CLUB: 6.01 (-0.04), SPLS: 14.24 (-0.19), FNHC: 24.54 (+0.60), AGIO: 104.05 (+2.03), OPLK: 24.19 (+0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 11:55AM CST
CLUB: 6.01 (-0.04), LEJU: 12.00 (-0.17), ANV: 1.56 (-0.15), SSI: 19.52 (-0.41), ROX: 1.58 (+0.07), CLF: 8.03 (-0.57), BIND: 6.14 (-0.58), NADL: 1.97 (-0.20), CSTM: 17.53 (+0.98), VRML: 1.37 (unch), WTT: 2.62 (+0.09), CANF: 4.04 (-0.23), DL: 17.84 (-0.28), BAMM: 1.87 (+0.03), RELV: 1.25 (+0.03), SNCR: 42.09 (+0.10), ATLC: 2.62 (-0.15), AGIO: 104.05 (+2.03), BBLU: 0.99 (-0.02), OPLK: 24.19 (+0.01)
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'
at The Street - Wed Nov 19, 10:21AM CST
TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.
AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - Wed Nov 19, 8:11AM CST
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 14.24 (-0.19), LEJU: 12.00 (-0.17), TSLA: 228.28 (-1.02), FCAU: 13.22 (-0.34), LITB: 6.12 (-0.37), TTM: 45.39 (-1.65), DL: 17.84 (-0.28), VA: 35.64 (-0.13), TGT: 73.28 (-0.05), GM: 33.09 (-0.55), AGIO: 104.05 (+2.03), LOW: 64.55 (+0.25), HMC: 31.21 (+0.23), EJ: 9.04 (+0.11), PETM: 79.11 (-0.33)
Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:01AM CST
AGIO: 104.05 (+2.03)
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)
